These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 30666020

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of the BCR-ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid Leukemia.
    Rostami G, Hamid M, Jalaeikhoo H.
    Gene; 2017 Sep 05; 627():202-206. PubMed ID: 28627443
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions.
    May PC, Reid AG, Robinson ME, Khorashad JS, Milojkovic D, Claudiani S, Genomics England Research Consortium, Willis F, Apperley JF, Innes AJ.
    BMC Med Genomics; 2023 Jul 26; 16(1):172. PubMed ID: 37496024
    [Abstract] [Full Text] [Related]

  • 7. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage.
    Elmaagacli AH, Beelen DW, Opalka B, Seeber S, Schaefer UW.
    Ann Hematol; 2000 Aug 26; 79(8):424-31. PubMed ID: 10985361
    [Abstract] [Full Text] [Related]

  • 8. A unique BCR-ABL1 transcript with the insertion of intronic sequence from BCR and ABL1 genes in a patient with Philadelphia-positive chronic myeloid leukemia: a case study.
    Sadia H, Siddiqui RT, Nasim A.
    Cancer Genet Cytogenet; 2010 Aug 26; 201(1):57-61. PubMed ID: 20633771
    [Abstract] [Full Text] [Related]

  • 9. Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients.
    Arun AK, Senthamizhselvi A, Mani S, Vinodhini K, Janet NB, Lakshmi KM, Abraham A, George B, Srivastava A, Srivastava VM, Mathews V, Balasubramanian P.
    Int J Lab Hematol; 2017 Jun 26; 39(3):235-242. PubMed ID: 28035733
    [Abstract] [Full Text] [Related]

  • 10. The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
    Castagnetti F, Gugliotta G, Breccia M, Iurlo A, Levato L, Albano F, Vigneri P, Abruzzese E, Rossi G, Rupoli S, Cavazzini F, Martino B, Orlandi E, Pregno P, Annunziata M, Usala E, Tiribelli M, Sica S, Bonifacio M, Fava C, Gherlinzoni F, Bocchia M, Soverini S, Bochicchio MT, Cavo M, Giovanni M, Saglio G, Pane F, Baccarani M, Rosti G, GIMEMA CML Working Party.
    Am J Hematol; 2017 Aug 26; 92(8):797-805. PubMed ID: 28466557
    [Abstract] [Full Text] [Related]

  • 11. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M, Ghaffari SH, Ghavamzadeh A, Alimoghaddam K, Jahani M, Mousavi SA, Irvani M, Bahar B, Bibordi I.
    Arch Iran Med; 2008 May 26; 11(3):247-51. PubMed ID: 18426313
    [Abstract] [Full Text] [Related]

  • 12. BCR/ABL1 Transcripts in Healthy Individuals: A Comparative Analysis Between First-Degree Relatives of Patients with Chronic Myelogenous Leukemia and Subjects without Antecedents of the Disease.
    Meza-Espinoza JP, Vásquez-Jiménez EA, Barajas-Torres RL, Magaña-Torres MT, González-García JR.
    Ann Clin Lab Sci; 2019 Nov 26; 49(6):703-709. PubMed ID: 31882420
    [Abstract] [Full Text] [Related]

  • 13. A review on characterization of BCR - ABL transcript variants for molecular monitoring of chronic myeloid leukemia phenotypes.
    Zenebe B, Nigussie H, Belay G, Seboka N.
    Hematology; 2023 Dec 26; 28(1):2284038. PubMed ID: 37982440
    [Abstract] [Full Text] [Related]

  • 14. BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR.
    Zagaria A, Anelli L, Coccaro N, Tota G, Casieri P, Cellamare A, Impera L, Brunetti C, Minervini A, Minervini CF, Delia M, Cumbo C, Orsini P, Specchia G, Albano F.
    Virchows Arch; 2015 Sep 26; 467(3):357-63. PubMed ID: 26149409
    [Abstract] [Full Text] [Related]

  • 15. A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib.
    Kitamura H, Tabe Y, Ai T, Tsuchiya K, Yuri M, Misawa S, Horii T, Kawaguchi A, Ohsaka A, Kimura S.
    PLoS One; 2019 Sep 26; 14(3):e0207170. PubMed ID: 30835732
    [Abstract] [Full Text] [Related]

  • 16. Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.
    Bennour A, Ouahchi I, Moez M, Elloumi M, Khelif A, Saad A, Sennana H.
    Clin Lab; 2012 Sep 26; 58(5-6):433-9. PubMed ID: 22783572
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre.
    Qin YZ, Jiang Q, Jiang H, Lai YY, Shi HX, Chen WM, Yu L, Huang XJ.
    Br J Haematol; 2018 Sep 26; 182(5):693-700. PubMed ID: 29974949
    [Abstract] [Full Text] [Related]

  • 18. BCR-ABL1 transcript levels increase in peripheral blood but not in granulocytes after physical exercise in patients with chronic myeloid leukemia.
    Jönsson S, Olsson B, Jacobsson S, Palmqvist L, Ricksten A, Ekeland-Sjöberg K, Wadenvik H.
    Scand J Clin Lab Invest; 2011 Feb 26; 71(1):7-11. PubMed ID: 20863169
    [Abstract] [Full Text] [Related]

  • 19. Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network.
    Schäfer V, White HE, Gerrard G, Möbius S, Saussele S, Franke GN, Mahon FX, Talmaci R, Colomer D, Soverini S, Machova Polakova K, Cross NCP, Hochhaus A, Ernst T.
    J Cancer Res Clin Oncol; 2021 Oct 26; 147(10):3081-3089. PubMed ID: 33677711
    [Abstract] [Full Text] [Related]

  • 20. Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib.
    Hanfstein B, Lauseker M, Hehlmann R, Saussele S, Erben P, Dietz C, Fabarius A, Proetel U, Schnittger S, Haferlach C, Krause SW, Schubert J, Einsele H, Hänel M, Dengler J, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Baerlocher GM, Pfirrmann M, Hasford J, Hofmann WK, Hochhaus A, Müller MC, SAKK and the German CML Study Group.
    Haematologica; 2014 Sep 26; 99(9):1441-7. PubMed ID: 24837466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.